Biperiden

Generic Name
Biperiden
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C21H29NO
CAS Number
514-65-8
Unique Ingredient Identifier
0FRP6G56LD
Background

A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.

Indication

用于治疗震颤麻痹及药物引起的锥体外系症状。

Associated Conditions
Extrapyramidal Symptoms, Extrapyramidal disorder caused by neuroleptic drugs without Tardive dyskinesia, Parkinson's Disease (PD), Poisoning caused by Nicotine, Poisoning caused by organophosphorus pesticides
Associated Therapies
-
Clinical Trials
Related News

Biperiden Trial for Epilepsy Prevention

First Posted Date
2021-06-30
Last Posted Date
2024-03-26
Lead Sponsor
Hospital Sirio-Libanes
Target Recruit Count
312
Registration Number
NCT04945213
Locations
🇧🇷

Hospital das Clínicas da Faculdade de Medicina da Universidade de Ribeirão Preto, Ribeirão Preto, SP, Brazil

🇧🇷

Hospital São Vicente de Paulo, Passo Fundo, RS, Brazil

🇧🇷

Hospital São Paulo, Universidade Federal de São Paulo, São Paulo, Brazil

and more 7 locations

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Dementia
Depression
Schizophrenia
Psychosomatic Disorders
Anxiety Disorders
Interventions
Drug: Phenobarbital
Drug: Phenytoin
Drug: Carbamazepine
Drug: Oxcarbazepine
Drug: Valproic Acid
Drug: Lamotrigine
Drug: Topiramate
Drug: Gabapentin
Drug: Levetiracetam
Drug: Pregabalin
Drug: Lacosamide
Drug: Clonazepam
Drug: Biperiden
Drug: Levomepromazine
Drug: Fluphenazine
Drug: Perphenazine
Drug: Perazine
Drug: Thioridazine
Drug: Haloperidol
Drug: Melperone
Drug: Pipamperone
Drug: Bromperidol
Drug: Benperidol
Drug: Sertindole
Drug: Ziprasidone
Drug: Flupentixol
Drug: Chlorprothixene
Drug: Zuclopenthixol
Drug: Fluspirilene
Drug: Pimozide
Drug: Clozapine
Drug: Olanzapine
Drug: Quetiapine
Drug: Sulpiride
Drug: Tiapride
Drug: Amisulpride
Drug: Prothipendyl
Drug: Risperidone
Drug: Aripiprazole
Drug: Paliperidone
Drug: Diazepam
Drug: Oxazepam
Drug: Lorazepam
Drug: Bromazepam
Drug: Clobazam
Drug: Alprazolam
Drug: Hydroxyzine
Drug: Buspirone
Drug: Chloral Hydrate
Drug: Flurazepam
Drug: Nitrazepam
Drug: Triazolam
Drug: Lormetazepam
Drug: Temazepam
Drug: Midazolam
Drug: Brotizolam
Drug: Zopiclone
Drug: Zolpidem
Drug: Zaleplon
Drug: Melatonin
Drug: Clomethiazole
Drug: Diphenhydramine
Drug: Promethazine
Drug: Imipramine
Drug: Clomipramine
Drug: Opipramol
Drug: Trimipramine
Drug: Amitriptyline
Drug: Nortriptyline
Drug: Doxepin
Drug: Maprotiline
Drug: Amitriptyline oxide
Drug: Fluoxetine
Drug: Citalopram
Drug: Paroxetine
Drug: Sertraline
Drug: Fluvoxamine
Drug: Escitalopram
Drug: Tranylcypromine
Drug: Moclobemide
Drug: Mianserin
Drug: Trazodone
Drug: Mirtazapine
Drug: Bupropion
Drug: Venlafaxine
Drug: Reboxetine
Drug: Duloxetine
Drug: Agomelatine
Drug: Pyritinol
Drug: Piracetam
Drug: Donepezil
Drug: Rivastigmine
Drug: Galantamine
Drug: Memantine
Drug: Nicergoline
Drug: Acamprosate
Drug: Lithium
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations

Cocaine/Crack and Reduction of Compulsion With Biperiden

Phase 3
Completed
Conditions
Cocaine Dependence
Interventions
Drug: Biperiden
Drug: Placebo
First Posted Date
2010-12-01
Last Posted Date
2020-10-14
Lead Sponsor
Federal University of São Paulo
Target Recruit Count
111
Registration Number
NCT01251393
Locations
🇧🇷

UDED - Drug Dependence Unit, São Paulo, Brazil

Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients

First Posted Date
2007-07-02
Last Posted Date
2012-03-01
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
85
Registration Number
NCT00495092
Locations
🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain

Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence

First Posted Date
2007-07-02
Last Posted Date
2010-05-27
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
108
Registration Number
NCT00495183
Locations
🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy